Centrus Energy (LEU) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
9 Jul, 2026Executive summary
Achieved $73.1 million in revenue and $27.2 million net income in Q1 2025, reversing a $6.1 million loss in Q1 2024, driven by shipment timing, higher LEU segment sales, and improved contract mix.
Gross profit surged to $32.9 million from $4.3 million year-over-year, with operating income of $20.5 million.
Ended Q1 with $653 million in cash, supporting growth and expansion plans.
Redeemed all 8.25% Notes, recording an $11.8 million gain and reducing interest expense.
Backlog reached $3.8 billion, extending to 2040, with $2.8 billion in the LEU segment.
Financial highlights
Revenue increased by 67% year-over-year to $73.1 million, with LEU segment revenue up 117% to $51.3 million and Technical Solutions revenue up 8% to $21.8 million.
Gross profit rose to $32.9 million from $4.3 million, and LEU segment gross profit surged to $31.2 million from $0.5 million.
Operating income was $20.5 million, compared to a $10.6 million loss in Q1 2024.
Cash provided by operating activities was $36.5 million, up from $5.3 million.
Technical Solutions gross profit declined to $1.7 million from $3.8 million due to increased costs and contract delays.
Outlook and guidance
Positioned to expand uranium enrichment operations pending DOE and Congressional funding decisions, with $3.4 billion in potential federal support.
Backlog of $3.8 billion extends to 2040, with $2.8 billion in LEU and $0.9 billion in Technical Solutions.
No formal financial guidance provided; revenue timing driven by customer reload cycles and contract awards.
Capital expenditures of $23.3 million planned over the next 12 months, including $60 million for Oak Ridge expansion.
Confident in investment case as the only proven, publicly traded U.S. enricher ready to meet commercial and national security needs.
Latest events from Centrus Energy
- Q2 net income surged 141% to $30.6M on $189M revenue, with pension liabilities sharply reduced.LEU
Q2 20249 Jul 2026 - All proposals except the officer exculpation amendment passed; shareholder engagement increased.LEU
AGM 202624 Jun 2026 - Q1 2026 revenue up 5% to $76.7M, net income down, 2026 guidance raised amid expansion.LEU
Q1 20266 May 2026 - Proxy covers director elections, compensation, governance, and key amendments for 2026.LEU
Proxy filing24 Apr 2026 - Record revenue, new manufacturing program, and job creation drive nuclear sector growth.LEU
Proxy filing24 Apr 2026 - Key votes include director elections, executive pay, governance amendments, and auditor ratification.LEU
Proxy filing24 Apr 2026 - Virtual meeting to vote on directors, compensation, governance amendments, and auditor ratification.LEU
Proxy filing10 Apr 2026 - Exclusive U.S. HALEU enricher, expanding to meet surging demand as Russian supply exits.LEU
Investor presentation11 Feb 2026 - Record revenue, $900M HALEU award, and $3.8B backlog drive growth and expansion plans.LEU
Q4 202511 Feb 2026